Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant Recipients

15 September 2026 : Original article

Agnieszka Kuczaj

^{ABCDEFG 1*}, Szymon Warwas

^{BCDEF 1}, Mikołaj Tyrka

^{BDEF 1}, Błażej Skotnicki

^{BDEF 1}, Daniel Szymecki^{BDEF 1}, Oliwia Jewuła

^{BDEF 1}, Joanna Śliwka

^{ADEF 1}, Szymon Pawlak

^{ADEF 1}, Piotr Przybyłowski

^{ADEF 1}, Tomasz Hrapkowicz

^{ADEF 1}

DOI: 10.12659/AOT.952888

Ann Transplant 2026; 31:e952888

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Multivariable analysis of the clinical factors related to death due to COVID-19.

Clinical data	Odds ratio	95% CI	P value
Vaccinated	0.22	0.07–0.68	0.009
Diabetes mellitus type 2	2.05	0.53–7.90	0.30
Age (years)	1.08	1.02–1.14	0.008

Back to the Article